| Composition | Dapagliflozin 5mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 20×10 |
| Packing | Alu-Alu |
At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.
Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.
With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.
DAPACOP 5 Tablets
DAPACOP 5 is a prescription medicine containing Dapagliflozin 5 mg, an effective antidiabetic agent used for the management of type 2 diabetes mellitus. It belongs to the class of SGLT2 inhibitors, which help lower blood sugar levels by preventing the reabsorption of glucose in the kidneys and promoting its excretion through urine.
Doctors commonly prescribe DAPACOP 5 for patients whose blood glucose levels are not adequately controlled by diet, exercise, or other oral antidiabetic medications. It is often recommended as part of a comprehensive diabetes management plan, including lifestyle modifications such as a balanced diet, regular physical activity, and routine blood sugar monitoring.
The tablet should be taken once daily, preferably in the morning, with or without food, following the doctor’s instructions. Patients should not skip doses or discontinue the medication suddenly, as this may adversely affect glycemic control.
Some common side effects may include urinary tract infections, increased urination, or mild dehydration, which usually resolve with proper care. With consistent use under medical supervision, DAPACOP 5 helps maintain healthy blood sugar levels, reduces the risk of diabetes-related complications, and supports long-term metabolic and cardiovascular health.
